Slit3 inhibitors are a class of chemical compounds that target the Slit3 protein, a member of the Slit family of secreted proteins, which are known to play significant roles in cell signaling and guidance. Slit3 is involved in regulating cellular interactions, particularly in processes such as cell migration and tissue patterning, by binding to its corresponding receptor, Robo (Roundabout). Slit3 inhibitors function by interfering with the interaction between Slit3 and Robo receptors, thereby modulating the signaling pathways that Slit3 influences. These inhibitors often work by binding to specific domains on the Slit3 protein, preventing it from interacting with Robo receptors or altering the protein's structure to inhibit its activity. By doing so, they disrupt the signaling cascades that are initiated by Slit3, impacting cellular behavior and organization.
The chemical structures of Slit3 inhibitors can be quite varied, ranging from small molecule inhibitors to larger peptide-based compounds. These molecules are typically designed to specifically interact with the Slit3 protein at key binding sites, often mimicking the natural binding partners of Slit3 or blocking the protein's functional domains. The design and development of Slit3 inhibitors require a deep understanding of the protein's structure, its binding mechanisms, and the dynamics of its interaction with receptors like Robo. Research into these inhibitors helps elucidate the complex signaling pathways mediated by Slit3 and sheds light on how extracellular signals are translated into cellular responses. By studying these inhibitors, scientists are able to explore the regulatory mechanisms governing processes such as cell motility, growth, and development.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Inhibits the Hedgehog (Hh) signaling pathway, which may intersect with Slit/Robo signaling. | ||||||
Vismodegib | 879085-55-9 | sc-396759 sc-396759A | 10 mg 25 mg | $82.00 $158.00 | 1 | |
A Hedgehog pathway inhibitor, could indirectly affect Slit3 by modulating related pathways. | ||||||
Erismodegib | 956697-53-3 | sc-396280 sc-396280A | 10 mg 100 mg | $255.00 $918.00 | ||
Another Hedgehog pathway inhibitor, may have indirect effects on Slit3 signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, could influence Slit3 signaling indirectly through the PI3K/Akt pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, can affect various cellular pathways, potentially impacting Slit3 signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, could indirectly modulate Slit3-related signaling processes. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor, might influence Slit3 function given the role of ROCK in cell migration and morphology. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
A Rac1 inhibitor, could affect cellular processes related to Slit3 signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor, might indirectly impact Slit3 through stress response and inflammatory pathways. | ||||||
Wnt-C59 | 1243243-89-1 | sc-475634 sc-475634A sc-475634B | 5 mg 10 mg 50 mg | $214.00 $326.00 $1275.00 | 1 | |
Inhibits Wnt signaling, which may have cross-talk with Slit3-mediated pathways. | ||||||